Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pooja Talati
Pharmacologic Suppression of JAK1/2 by JAK1/2 Inhibitor AZD1480 Potently Inhibits IL-6-Induced Experimental Prostate Cancer Metastases Formation
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
FRI0428 the JAK1-selective Inhibitor, Filgotinib, Inhibits Inflammation Pathways Observed in an IL23-induced Psoriatic Arthritis Mouse Model
Human Dendritic Cells Mitigate NK-Cell Dysfunction Mediated by Nonselective JAK1/2 Blockade
Cancer immunology research
Cancer Research
Immunology
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
IL-6 Inhibits Starvation-Induced Autophagy via the STAT3/Bcl-2 Signaling Pathway
Scientific Reports
Multidisciplinary
Role of the IL-6-JAK1-STAT3-Oct-4 Pathway in the Conversion of Non-Stem Cancer Cells Into Cancer Stem-Like Cells
Cellular Signalling
Cell Biology
Matrine Increases the Inhibitory Effects of Afatinib on H1975 Cells via the IL-6/JAK1/STAT3 Signaling Pathway
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Effect of COX-2 (PGE2) and IL-6 on Prostate Cancer Bone Mets
HOXA10 Deteriorates Gastric Cancer Through Activating JAK1/STAT3 Signaling Pathway
Cancer Management and Research
Oncology
Thymic Stromal Lymphopoietin-Mediated STAT5 Phosphorylation via Kinases JAK1 and JAK2 Reveals a Key Difference From IL-7-induced Signaling
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary